Second primary cancer after female breast cancer: Familial risks and cause of death

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53062

language	eng
Author	Zheng Guoqiao Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany Hemminki Akseli Faculty of Medicine, Cancer Gene Therapy Group, University of Helsinki, Helsinki, Finland Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland Forsti Asta Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, Sweden Sundquist Jan Center for Primary Health Care Research, Lund University, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York Department of Functional Pathology, School of Medicine, Center for Community-based Healthcare Research and Education (CoHRE), Shimane University, Matsue, Japan Sundquist Kristina Center for Primary Health Care Research, Lund University, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York Department of Functional Pathology, School of Medicine, Center for Community-based Healthcare Research and Education (CoHRE), Shimane University, Matsue, Japan Hemmink Kari Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany Center for Primary Health Care Research, Lund University, Malmö, Sweden
Subject	cause of death; cumulative incidence; familial cancer; second cancer; survival rate
Journal Title	CANCER MEDICINE
Volume	8
Issue	1
Start Page	400
End Page	407
ISSN	2045-7634
Published Date	2019-01
DOI	10.1002/cam4.1899
PubMed ID	30479046
Publisher	WILEY
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This work was funded by the German Cancer Aid [K.H.]; Jane and Aatos Erkko Foundation [A.H.]; Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki and Helsinki University Central Hospital [A.H.]; the Swedish Research Council for Health, Working Life and Welfare (in Swedish: FORTE; Reg. no. 2013-1836 and Reg. no. 2014-0804) [K.S.]; the Swedish Research Council (2012-2378 and 2014-10134) [K.S.]; ALF funding from Region Skane [K.S.] and by the China Scholarship Council (201606100057, for doctoral student G.Z.).